Pharming Group N.V. ADR (PHAR-Q) Analyst Research & Price Targets - The Globe and Mail

Add to Watchlist Create Alerts

Real-Time Last Update

Last Sale Cboe BZX Real-Time

Volume

Current Target Price

High Target Price

Mean Target Price

Low Target Price

Median Target Price

Earnings Estimates

	Current Qtr06/2024	Next Qtr09/2024	Fiscal Yr12/2024	Fiscal Yr12/2025
Average Estimate	0.01	0.35	-0.03	-0.01
Number of Estimates	2	2	3	3
High Estimate	0.02	0.70	0.02	0.07
Low Estimate	0.00	0.01	-0.10	-0.10
Prior Year	0.02	0.05	-0.14	-0.03
Growth Rate Est. (year over year)	-50.00%	+600.00%	+78.57%	+66.67%

Earnings History - Surprises*

	Qtr Ending03/2024	Qtr Ending12/2023	Qtr Ending09/2023	Qtr Ending06/2023
Reported	$-0.19	$-0.03	$0.05	$0.02
Estimate	$0.01	$0.05	$0.13	$-0.02
Difference	-0.20	-0.08	-0.08	+0.04
Surprise	-2,000.00%	-160.00%	-61.54%	+200.00%

* Earnings are based on GAAP income from continuing operations.

Average Analyst Ratings

4.75

3 Mths Ago4

4.75

2 Mths Ago4

4.75

1 Mth Ago4

4.75

Current4

Ratings Values:

Strong Buy5

Moderate Buy4

Hold3

Moderate Sell2

Strong Sell1

Ratings Breakdown

	3 Mths Ago	2 Mths Ago	1 Mth Ago	Current
# of Analysts:	4	4	4	4
	3 1	3 1	3 1	3 1
Holds	0	0	0	0

Key:

Strong Buy

Moderate Buy

Hold

Moderate Sell

Strong Sell

More from The Globe

number cruncher

U.S technology stocks with earnings and price momentum

Lightspeed Commerce stock soars on better-than-expected profit forecast

GameStop, AMC continue to slide as meme stocks rally loses steam

The close: Dow briefly hits 40,000 milestone, TSX rises on upbeat earnings

Proxy advisers recommend investors vote ‘no’ on Shopify executive pay

The close: Wall Street boasts fresh records as inflation data fuels rate-cut bets

Chevron tops Tesla as most-shorted stock in April, says Hazeltree

The close: Nasdaq at record high after Fed chair’s comments but TSX dips for third day